Vaccine

Home The Pfizer/BioNTech coronavirus vaccine began, rather slowly, to be given to some old people in hospital and health workers. Margaret Keenan, 90, was the first outside clinical trials to receive it. At the beginning of the week, Sunday 6 December, total deaths (within 28 days of testing positive for the coronavirus) had stood at 61,014, including 2,771 in the past week; the number for the week before was 3,617. Rita Ora, the singer, a week after apologising for entertaining 30 people at a birthday party on the ‘spur of the moment’, remembered to apologise for not having gone into quarantine at the time, after returning from Egypt. England’s cricket

The eyes of the world were on Britain today, as the first patients began to receive the Pfizer vaccine, after it was cleared by Britain’s health regulators as safe to use. Unsurprisingly, foreign TV news channels sent their crews to British hospitals to witness the first patients receiving the jab. Outside Guy’s Hospital in London, CNN managed to catch up with one charming 91-year-old, who had managed to receive the jab after ringing up the hospital to see if they had any spare shots going. As Martin Kenyon explained though, his main difficulty in getting the vaccine was finding a parking spot in London. Mr Kenyon explained that he had

Home The Commons voted by 291 votes to 78 for new coronavirus regulations putting 55 million people in England into the restrictive Tier 3 or the little less restrictive Tier 2, apart from the 700,000 or so folk of Cornwall, the Isle of Wight and the Scilly Isles. There were 55 Tory rebels, whom the government had attempted to placate by publishing a 48-page dossier, generally regarded as thin stuff. There would, they were also assured, be a review on 16 December of the areas put into tiers. ‘We do want to be as granular as possible,’ Boris Johnson, the Prime Minister, told the Commons encouragingly. Labour let the regulations

It’s three for three as far as positive outcomes from Covid vaccine trials are concerned. But the announcement from AstraZeneca and Oxford University, at a first glance, may not seem to be as exciting as those from Pfizer-BioNTech and Moderna. The figures are a bit of a head-scratcher, so let’s look at them in more detail. Monday’s results from AstraZeneca and Oxford University state that the combined Phase 3 interim analysis from their COV002 and COV003 studies (based in the UK and Brazil respectively) included 131 Covid-19 cases and that the vaccine was found to be 70.4 per cent effective overall — but that vaccine efficacy in two dosing subgroups was

Still distant Sir: In James Forsyth’s analysis (‘Boris’s booster shot’, 14 November) he infers that a vaccine, if provided to the majority of the UK population, would deliver herd immunity from Covid-19, noting that ‘it seems increasingly probable that by the second half of next year, we will be emerging from this Covid nightmare’. I pray that he is right, though fear he may not be. In a recent Lancet editorial the view expressed was the exact opposite, as it notes that any vaccines are ‘unlikely’ to prevent transmission, though will reduce the severity of symptoms and likelihood of death. Critically, if transmission cannot be stopped via vaccine, in the

A couple of shots to the arm and this will all be over. With today’s news from Moderna, last week’s from Pfizer, and with a potential update from AstraZeneca in the next few days, we may soon have three vaccines against Covid-19 (and if you add in candidates from Russia and China perhaps more). And yet, it turns out, that some people are already fretting about potential side effects from that. And they don’t just mean a mild fever or muscle ache. They mean something far, far nastier. Profits. While most of us have been feeling a lot better about the epidemic over the last week, Jeremy Corbyn seems most